Declaration
The Company and all directors, members of the Board Audit Committee, and senior management warrant that the contents of this prospectus are true, accurate, and complete, and contain no false records, misleading statements, or major omissions. They undertake to perform their commitments in accordance with the principle of good faith and assume corresponding legal liabilities.
The Company's person-in-charge, the person-in-charge of accounting work, and the person-in-charge of the accounting institution (accounting supervisor) guarantee the truthfulness and completeness of the financial and accounting information in this prospectus.
Any decision or opinion made by the China Securities Regulatory Commission or the Shenzhen Stock Exchange regarding this issuance does not indicate their guarantee of the truthfulness, accuracy, or completeness of the application documents and disclosed information, nor does it constitute a substantive judgment or guarantee of the issuer's profitability, investment value, or investor returns. Any statement to the contrary is a false representation.
In accordance with the Securities Law, after the securities are issued in accordance with the law, the issuer is solely responsible for changes in its operations and earnings. Investors shall independently judge the investment value of the issuer, make their own investment decisions, and bear the investment risks arising from changes in the issuer's operations and earnings or fluctuations in securities prices after the issuance.
Important Matters Notice
The Company specifically reminds investors to read the full text of this prospectus carefully before making investment decisions and to pay special attention to the following important matters.
I. Overview of the Issuance of Shares to Specific Targets
-
Matters related to this issuance of shares to specific targets have been deliberated and approved by the Company's 40th meeting of the 5th Board of Directors, the 2023 3rd Extraordinary General Meeting, the 42nd meeting of the 5th Board of Directors, the 46th meeting of the 5th Board of Directors, the 2023 5th Extraordinary General Meeting, the 9th meeting of the 6th Board of Directors, the 2024 5th Extraordinary General Meeting, the 22nd meeting of the 6th Board of Directors, the 2025 3rd Extraordinary General Meeting, the 25th meeting of the 6th Board of Directors, the 35th meeting of the 6th Board of Directors, the 40th meeting of the 6th Board of Directors, and the 41st meeting of the 6th Board of Directors. It has passed the review by the Shenzhen Stock Exchange. According to relevant laws and regulations, this issuance is subject to the registration approval of the China Securities Regulatory Commission before it can be implemented. Upon approval, the Company will apply to the Shenzhen Stock Exchange and the Shenzhen Branch of China Securities Depository and Clearing Corporation for share issuance, registration, and listing, completing all reporting and approval procedures.
-
The number of targets for this issuance shall not exceed 35 (inclusive), consisting of securities investment fund management companies, securities companies, trust companies, finance companies, insurance institutional investors, qualified foreign institutional investors, other domestic corporate investors, and natural persons that meet the requirements of the China Securities Regulatory Commission. If a securities investment fund management company, securities company, qualified foreign institutional investor, or RMB qualified foreign institutional investor subscribes with two or more products under its management, it shall be regarded as one target. Trust companies subscribing as targets may only use their own funds.
The final targets will be determined by the Board of Directors within the scope authorized by the General Meeting of Shareholders, based on subscription quotations and in consultation with the sponsor (lead underwriter), after the application is approved by the Shenzhen Stock Exchange and registered by the China Securities Regulatory Commission.